Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-020935
Filing Date
2025-02-14
Accepted
2025-02-14 14:00:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4563
  Complete submission text file 0000950170-25-020935.txt   6277
Mailing Address 888 SEVENTH AVENUE 43RD FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 43RD FLOOR NEW YORK NY 10106 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

EIN.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93291 | Film No.: 25626482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)